Hereditary breast and ovarian cancer: new genes in confined pathways.
about
Classification of the spliceogenic BRCA1 c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrierFunctional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families.SNM1B/Apollo in the DNA damage response and telomere maintenanceRecent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.Evaluation of psychosocial aspects in participants of cancer genetic counselingCHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer.Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.Ovarian Cancer Prevention in High-risk Women.Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma.Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.The Long Noncoding RNA HOTAIR in Breast Cancer: Does Autophagy Play a Role?Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells.PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.Characterization of basal-like subtype in a Danish consecutive primary breast cancer cohort.MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation.[BRCA diagnostics of ovarian cancer : Molecular tumor testing since the introduction of PARP inhibitor therapy].Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays.Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.Exploration of genetic basis underlying individual differences in radiosensitivity within human populations using genome editing technology.DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.Repeat-mediated deletions can be induced by a chromosomal break far from a repeat, but multiple pathways suppress such rearrangementsThe Ethnic-Specific Spectrum of Germline Nucleotide Variants in DNA Damage Response and Repair Genes in Hereditary Breast and Ovarian Cancer Patients of Tatar DescentEnvironmental toxicant induced epigenetic transgenerational inheritance of ovarian pathology and granulosa cell epigenome and transcriptome alterations: ancestral origins of polycystic ovarian syndrome and primary ovarian insufiencyComprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
P2860
Q33761082-BB6C853D-6D56-4329-A900-163304421CB3Q36322003-EFF76EFC-A2F7-44A7-8B87-427A27FB38F4Q37709179-01E929FB-8456-4045-A972-10ECE9152A88Q37725110-48ABFFA3-FD55-46AB-B4F9-2D34BF0BDD03Q39254699-1C58CE92-4AA3-4122-BEF5-4772005C00E6Q39309080-CC9356B1-FBC7-4612-9A19-246B513530A8Q41470898-FF2B42F3-E390-4EB6-8E24-30846551BD3BQ41696212-8C569B7E-199A-4E46-BB78-202A024006B7Q41717913-E95EC0FC-64AB-48E4-B4D9-45AEC7E93505Q42261796-ADFC8462-B610-40FD-B06A-C5AD1D341E37Q45068704-D21A5BA5-6781-426D-862C-DF296A3F7A90Q47110043-31A447B5-4A80-48A6-9B65-71AB04C0205CQ47138752-BC20C906-9465-4624-A9C4-5A3155663EB2Q47141035-CF1459AD-52B0-4849-B682-324C9A13C2C4Q47161502-25D3688B-556E-4FB4-8533-932B8097DB1AQ48771383-77F68DB4-B608-41A9-9E8E-AF3862329784Q49723005-32463D82-BFA9-47DE-9C29-88216DD1EC5BQ49818569-1E525C59-867A-409E-B1D6-8CAA5F8D7EBCQ50327592-3A918BBB-67AB-49B2-93F8-90B29C80E407Q52660676-0B198EB3-DE4C-4807-A28B-9598B674CBCCQ53465543-4311E0EE-24B3-4E96-A561-7836F4BF864DQ54917737-301F03AA-72F4-4578-87E1-CB4D087512A0Q55219319-445D87CF-FEAF-46E0-80B3-FB9FA783C2A8Q55273319-94E0B2F9-04C3-4796-89BE-A9DCA7EA7EA5Q55425717-A7F8100C-5E38-4EF7-8BDC-9B25D09C6178Q57753966-943ED8FB-B9D5-46F9-BE40-87D12C4476A1Q58586826-83EA916C-03B0-47C5-AC7B-9C31440B4EDAQ58788037-D6C4F138-5D7B-46F2-8C2A-FFF73883BFF1Q58930584-1E0EA227-6F7D-464A-8078-F9892413CF18
P2860
Hereditary breast and ovarian cancer: new genes in confined pathways.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hereditary breast and ovarian cancer: new genes in confined pathways.
@en
type
label
Hereditary breast and ovarian cancer: new genes in confined pathways.
@en
prefLabel
Hereditary breast and ovarian cancer: new genes in confined pathways.
@en
P2860
P356
P1476
Hereditary breast and ovarian cancer: new genes in confined pathways.
@en
P2093
Claus Storgaard Sørensen
Thomas van Overeem Hansen
P2860
P2888
P304
P356
10.1038/NRC.2016.72
P407
P577
2016-08-12T00:00:00Z
P6179
1034218927